Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
NEURAXIS INC

NRXS

$7.86Aug 09, 2023 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$79M
MVM
-$0.5M
TD Variance
-2.444

Every news event mapped to its market reaction — 70 events, 33 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-12-19+38.7%newsStocksToTradeWhy NeurAxis Stock Climbed 15% - StocksToTrade
2024-11-12+26.7%earningsSeeking AlphaNeurAxis reports Q3 results
2025-05-21-22.4%newsSeeking AlphaNeurAxis slides 21%, raises $5M via stock
2025-05-21-22.4%newsGlobeNewswireNeurAxis Announces $5.0 Million Registered Direct Offering - GlobeNewswire
2025-05-21-22.4%expansionInvesting.comNeuraxis settles lawsuit with $750,000 agreement - Investing.com
2023-08-22+15.9%newsTradingViewNRXS Stock Price and Chart — AMEX:NRXS - TradingView
2023-09-22+15.2%earningsSeeking AlphaNeurAxis GAAP EPS of -$1.21, revenue of $646K
2023-11-21+13.5%earningsSeeking AlphaNeurAxis reports Q3 results
2025-10-26-12.1%newsStocksToTradeNRXS Stock Falters Amid Market Headwinds and Investor Uncertainty - StocksToTrade
2025-10-25-12.1%newstimothysykes.comNeuraxis Inc. Faces Market Uncertainty Amid Financial Struggles - timothysykes.com
2023-09-02-11.3%newsSeeking AlphaStocks To Watch: Conferences And Fedspeak To Dominate Holiday-Shortened Week
2023-11-14+11.1%legalSeeking AlphaNeurAxis secures $3M financing through preferred stock offering
2025-05-12+11.0%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript
2025-05-12+11.0%earningsSeeking AlphaNeurAxis GAAP EPS of -$0.33, revenue of $0.89M
2025-05-12+11.0%earningsSeeking AlphaNeurAxis GAAP EPS of -$0.33, revenue of $0.90M misses by $724.1M
2026-03-19+11.0%earningsGuruFocus.comNeuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges
2026-03-19+11.0%earningsMobyNeurAxis, Inc. Q4 2025 Earnings Call Summary
2026-03-19+11.0%newsGlobeNewswireNeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results
2026-03-19+11.0%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript
2026-03-19+11.0%earningsSeeking AlphaNeurAxis reports Q4 results
2026-03-19+11.0%newsGlobeNewswireNeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire
2026-03-19+11.0%newsStock TitanNeurAxis says its pain-treatment device now reaches 100M insured lives - Stock Titan
2024-08-09+10.7%earningsSeeking AlphaNeurAxis reports Q2 results
2024-08-09+10.7%newsChartMillNRXS Ownership | NEURAXIS INC (NYSEARCA:NRXS) - ChartMill
2026-03-12+8.4%newsGlobeNewswireNeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
2026-04-21+6.9%newsStock TitanNeuraxis (NRXS) raises at‑the‑market capacity to $11.5M via Craig‑Hallum - Stock Titan
2026-04-21+6.9%earningsStock TitanNeuraxis (NYSE: NRXS) releases preliminary Q1 2026 financial results - Stock Titan
2025-05-30-6.0%newsIntellectia AINRXS Forecast — Price Prediction for 2026. Should I Buy NRXS? - Intellectia AI
2024-12-13-5.3%legalSeeking AlphaNeurAxis files for secondary mixed shelf offering
2026-03-22-5.1%newsStock TitanIf You Invested $1,000 in Neuraxis Inc (NRXS) - Stock Titan
2023-11-12-5.0%analystTradingViewNRXS Forecast — Price Target — Prediction for 2027 - TradingView
2025-05-22-4.7%legalStock TitanNeurAxis Raises $5M to Expand Revolutionary FDA-Cleared Treatment for Children's Chronic Abdominal Pain - Stock Titan
2026-04-10-4.5%newsGlobeNewswireNeurAxis, Inc. Announces Preferred Stock Dividend
2026-04-10-4.5%newsGlobeNewswireNeurAxis, Inc. Announces Preferred Stock Dividend - GlobeNewswire
2026-04-10-4.5%newsQuiver QuantitativeNeurAxis, Inc. Declares Stock Dividend on Series B Preferred Stock - Quiver Quantitative
2024-04-09-4.4%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript
2024-11-15-4.3%earningsSeeking AlphaNeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript
2024-04-12+2.9%earningsSeeking AlphaNeurAxis reports Q4 results
2024-06-07-2.9%earningsSeeking AlphaNeurAxis announces new submission to FDA for expansion of its IB-Stim label
2026-04-18-2.8%newsCổng thông tin điện tử tỉnh Tây NinhIs Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Shared Trade Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
2026-04-18-2.8%newsXã Thanh HàIs Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18 - Market Timing - Xã Thanh Hà
2026-04-18-2.8%newsCổng thông tin điện tử tỉnh Lào CaiNeuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18 - Volatility Breakout - Cổng thông tin điện tử tỉnh Lào Cai
2026-03-24+2.5%earningsZacksNeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth
2026-03-24+2.5%earningsYahoo FinanceNeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - Yahoo Finance
2024-03-28-2.5%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2025-01-08-2.5%earningsSeeking AlphaNeurAxis announces Q4 preliminary unaudited revenues were about $800 thousand
2024-08-11+1.9%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript
2025-01-25+1.7%newsSeeking AlphaNeurAxis Has Crafted An Inflection Point
2026-04-03+1.7%executiveInvesting.comNeuraxis CEO Carrico buys $15,797 in company stock - Investing.com
2026-04-03+1.7%executiveStock TitanNeuraxis (NRXS) CEO boosts stake with open-market buy of 8,060 shares - Stock Titan
2026-04-03+1.7%M&AStock TitanNeuraxis (NRXS) CFO acquires 7,593 shares at $1.96 in open trade - Stock Titan
2026-04-03+1.7%newsStock TitanNeuraxis (NRXS) executive makes small open-market share purchase - Stock Titan
2026-04-03+1.7%executiveInvesting.comNeuraxis CFO Henrichs buys $14,882 in company stock - Investing.com
2026-04-03+1.7%newsTipRanksTop NeurAxis Insiders Make Bold Moves With Fresh Stock Buys - TipRanks
2026-04-22+1.7%newsGlobeNewswireNeurAxis Expands Payer Coverage with Four New Medical Policies
2026-04-22+1.7%newsStock TitanNeuraxis (NRXS) boosts at-the-market share sale capacity to $11.5M - Stock Titan
2026-04-22+1.7%newsTipRanksNeurAxis Expands At-The-Market Equity Offering Capacity - TipRanks
2026-04-22+1.7%newsStock Titan1.25 million more people gain access to NeurAxis' IBS pain device - Stock Titan
2025-03-20+1.4%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript
2025-03-20+1.4%earningsSeeking AlphaNeurAxis reports Q4 results
2025-03-20+1.4%earningsStock TitanNeurAxis Delivers Record Q4: 43% Revenue Growth Plus Major FDA and Insurance Wins - Stock Titan
2025-11-11+1.3%newsSeeking AlphaNeurAxis outlines commercial readiness for 2026 as double-digit growth continues and CPT code milestone nears
2025-11-11+1.3%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript
2025-11-11+1.3%earningsSeeking AlphaNeurAxis reports Q3 results
2024-01-31-0.9%executiveSeeking AlphaNeurAxis appoints Timothy Henrichs as its CFO
2024-05-22+0.4%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript
2024-05-22+0.4%earningsSeeking AlphaNeurAxis GAAP EPS of -$0.32, revenue of $0.65M
2025-08-12-0.2%earningsSeeking AlphaNeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript
2025-08-12-0.2%earningsSeeking AlphaNeurAxis reports Q2 results
2026-04-24—analystChartMillNRXS Forecast, Price Target & Analyst Ratings | NEURAXIS INC (NYSEARCA:NRXS) - ChartMill
tickerdossier.comtickerdossier.substack.com